Inhibition of complement disrupts neurodegeneration, improves cognitive function in TBI patients

By | March 9, 2021
Traumatic brain injury (TBI) is a major cause of disability and a risk factor for early-onset dementia. The injury is characterized by a physical insult followed acutely by complement driven neuroinflammation.